Glenmark Q3 profit jumps nearly five-fold to Rs 212.91 cr
Jan 29 2013 , New Delhi
The company had posted a net profit of Rs 44.82 crore for the corresponding period in the previous fiscal, Glenmark Pharmaceuticals said in a statement.
Consolidated net sales of the company also rose to Rs 1,381.25 crore for the quarter under consideration from Rs 1,031.08 crore for the same period last fiscal.
Shares of Glenmark Pharmaceuticals today closed at Rs 504.05 per scrip on BSE, at same per cent from its previous close.